3S-indole methyl-6R-N-containing heterocyclic amino acid modified piperazine-2,5-dione, synthesis, activities and applications thereof

A technology of n-hexanoylamino and amino, applied in the preparation of anti-tumor metastasis drugs and anti-inflammatory drugs, in the field of -3--6--piperazine-2,5-dione, can solve the problem of poor clinical efficacy of tumor chemotherapy Ideal, no anti-tumor metastases and other issues

Inactive Publication Date: 2018-12-11
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the existing anti-tumor drugs have no anti-tumor metast...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 3S-indole methyl-6R-N-containing heterocyclic amino acid modified piperazine-2,5-dione, synthesis, activities and applications thereof
  • 3S-indole methyl-6R-N-containing heterocyclic amino acid modified piperazine-2,5-dione, synthesis, activities and applications thereof
  • 3S-indole methyl-6R-N-containing heterocyclic amino acid modified piperazine-2,5-dione, synthesis, activities and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1 prepares Boc-Lys(Cbz)-D-Trp-OBzl

[0019] Suspend 4.56g (10mmol) L-Boc-Lys (Cbz) in 100mL of anhydrous tetrahydrofuran (THF), and add 1.35g (10mmol) 1-hydroxybenzotriazole ( HOBt) and 2.47g (12mmol) of dicyclohexylcarbodiimide (DCC), then stirred for 30min. Afterwards, 3.31 g (10 mmol) of D-Trp-OBzl were added. The reaction compound was added dropwise to N-methylmorpholine (NMM) to adjust the pH to 9. The reaction mixture was first stirred under ice bath for 1 h, and then stirred at room temperature for 12 h. The reaction mixture was filtered, the filtrate was concentrated under reduced pressure, and the residue was dissolved in 150 mL of ethyl acetate solution. The obtained ethyl acetate solution was sequentially washed with 5% KHSO 4 Wash 3 times with aqueous solution and 3 times with saturated NaCl aqueous solution. Ethyl acetate layer with anhydrous Na 2 SO 4 Dry for 12h, filter, and concentrate the filtrate to dryness under reduced pressure. Th...

Embodiment 2

[0020] Embodiment 2 prepares Lys(Cbz)-D-Trp-OBzl

[0021] 3.28 g (5 mmol) Boc-Lys(Cbz)-D-Trp-OBzl was slowly mixed with 52 mL of hydrogen chloride in ethyl acetate under stirring in an ice bath. The resulting solution was stirred for 5 h in an ice bath. After that, the reaction mixture was concentrated under reduced pressure. The residue was dissolved in 50 mL of anhydrous ethyl acetate, and the resulting solution was concentrated under reduced pressure. This operation was repeated three times. The residue was washed well with anhydrous ether to obtain 2.36 g (85%) of the title compound as a colorless powder. ESI-MS(m / e):557[M+H] + .

Embodiment 3

[0022] Example 3 Preparation of (3S, 6R)-3-(benzyloxycarbonylamino-n-butyl)-6-(indole-3-methyl)-piperazine-2,5-dione (1)

[0023] Dissolve 2.22 g (4 mmol) of L-Lys(Cbz)-D-Trp-OBzl in 100 ml of ethyl acetate, adjust the pH to 9 with triethylamine, and stir at 80° C. for 100 hours. A colorless solid was filtered off. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (CH 2 Cl 2 / CH 3 OH, 100 / 1). A total of 1.32 g (65%) of the title compound was obtained. ESI-MS(m / e):449[M+H] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses (3S,6R)-3-(AA-amino-n-hexanoylamino-n-butyl)-6-(indole-3-methyl)-piperazine-2,5-dione represented by the following formula (AA is L-His residue and L-Trp residue), a preparation method, anti-tumor-metastasis activity and anti-inflammatory activity thereof, such that the present invention discloses applications of the (3S,6R)-3-(AA-amino-n-hexanoylamino-n-butyl)-6-(indole-3-methyl)-piperazine-2,5-dione in preparation of anti-tumor-metastasis drugs and anti-inflammatory drugs. The formula is defined in the specification.

Description

technical field [0001] The present invention relates to (3S,6R)-3-(AA-amino-n-hexanoylamino-n-butyl)-6-(indole-3-methyl)-piperazine-2,5-dione. It relates to their preparation method, their anti-tumor metastasis activity, and their anti-inflammation activity, so the present invention relates to their application in the preparation of anti-tumor metastasis medicine and anti-inflammatory medicine. The invention belongs to the field of biomedicine. Background technique [0002] Tumors seriously threaten human health. In addition to the poor prognosis of cancer patients, the concurrent metastasis of tumors further worsens the prognosis of patients. For example, more than 90% of cancer patients died of metastasis. Because the existing anti-tumor drugs have no anti-tumor metastasis effect, the clinical curative effect of tumor chemotherapy is unsatisfactory. It is an urgent clinical need to invent drugs against tumor metastasis. Previously, the inventors had disclosed that dik...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D403/06A61P35/04A61P29/00
CPCC07B2200/07C07D403/06
Inventor 赵明彭师奇吴建辉王玉记胡明芳
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap